Revenue

Bionano Genomics brings back OGM pioneer Dr. Alex Hastie as CSO. It's a strategic move to accelerate clinical adoption and restore investor confidence.

As automation floods the ad world, Bottle Rocket Media's handcrafted anniversary campaign argues that human creativity delivers an ROI that algorithms can't match.

Incoming Nuwellis CEO Mike McCormick lays out a bold growth plan targeting critically ill children, but a closer look reveals a precarious financial balancing act.

The mining giant’s dividend boost isn't just a shareholder reward; it's a bold signal of confidence in a supercharged copper market. What's the story here?

Canaan's CEO and CFO just bought over a million shares. Is this a signal of deep value or a risky bet on a new strategy in a volatile market?

Beyond the numbers, Crown Holdings' upcoming earnings reveal a story of economic health, consumer shifts, and the urgent push for sustainable packaging.

Heparin, a trusted blood thinner, can trigger a fatal immune reaction. A small biotech's novel drug is now taking the global stage with a targeted solution.

As McKesson prepares its August 5th earnings, all eyes are on its strategic overhaul. Will bold moves in oncology and tech deliver on profit promises?

Despite passing all resolutions, Novavax faces a reckoning as nearly half of shareholders reject its pay plan, amplifying activist investor Shah Capital's demands.

Facing delisting, Virax Biolabs consolidates its shares in a bid to survive. This move buys time, but the real test lies in its innovative T-cell technology.

Mace Consult lands at #7 on ENR's prestigious list, backed by Goldman Sachs and over $1B in revenue. How are they using AI to deliver certainty on the world's largest projects?

Veritone's upcoming AI showcase is a critical test. Can its impressive technological advancements overcome serious financial headwinds and prove its value?

Workiz's new AI platform merges daily operations with automated marketing, promising a 20% revenue boost for field service businesses. Is this the future of SMB growth?

As enterprise AI shifts from pilots to production, Nimble.LA doubles revenue and stacks its board with M&A and tech titans, signaling a market-wide race for tangible results.

A new partnership aims to boost sales by 491% for home service pros by turning digital job updates into physical postcards. Is this the future of marketing?

As Standex CEO David Dunbar prepares for the CJS New Ideas Conference, we analyze the firm's strategic pivot toward high-growth tech and what's at stake.

Southern Michigan Bancorp's consistent dividend signals more than shareholder return; it reflects deep regional economic health and savvy navigation.

PetVivo's acquisition of PiezoBioMembrane signals a bold leap from animal care to human health, leveraging advanced biomaterials to chase a larger market.

Beyond a simple contract renewal, the 50-year partnership between GXO and Carrefour reveals a blueprint for supply chain success built on trust and tech.

Spire Global's latest satellite deployment is more than just hardware heading to orbit. It's a masterclass in vertical integration and a key signal for investors.